Delivery Order SPE2DB22D2211-SPE2DB24FLYQ3
- Not listed
- This federal contract award is for the delivery of RIZATRIPTAN 10 MG ODT UD 3S, a pharmaceutical product, by Amerisourcebergen Drug Corp to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,262.44 and a completion date of September 29, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00. This IDC serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,980.91, is for the delivery of RIZATRIPTAN 10 MG ODT UD 3S, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of May 10, 2023. The contract was not designated with a set-aside. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,876.29 Delivery Order covers the supply of 4563282943 ! RIZATRIPTAN 5 MG ODT UD 3S, a prescription medication, with a period of performance ending on January 10, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,750.34 firm fixed-price delivery order is for the supply of RIZATRIPTAN 10 MG ODT UD 3S, a pharmaceutical product, with an ultimate completion date of April 20, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $1,436.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of 4565111851 - RIZATRIPTAN 10 MG ODT UD 18S, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of July 11, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
- The federal contract award, valued at $26,465.04, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of RIZATRIPTAN 5 MG ODT UD 3S. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC enables efficient government procurement of essential pharmaceutical and medical supplies to support...
- This federal contract award, valued at $5,831.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIZATRIPTAN 10 MG ODT UD 3S, a pharmaceutical product, with a completion date of May 5, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order, valued at $1,313.42, is for the supply of RIZATRIPTAN 5 MG ODT UD 18S, a pharmaceutical product. The contract is a firm-fixed-price delivery order with a completion date of September 18, 2024. This order is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds numerous federal contracts,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,104.12 firm fixed-price delivery order is for the supply of RIZATRIPTAN 10 MG TABLET UD 18S, with a performance period through February 14, 2025. The contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $1,346.16, is a delivery order for the pharmaceutical product RIZATRIPTAN 10 MG ODT UD 18S. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FLYQ3Delivery Order
This federal contract award is for the delivery of RIZATRIPTAN 10 MG ODT UD 3S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price type, valued at $95,673.52, and has an ultimate completion date of October 13, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $95.7k | 10/12/23 |